Rob van der Weegen is Principal Scientist and Group Lead at Ardena. He specializes in GMP-compliant process development and scale-up of complex nanoscale therapeutic modalities supporting clinical studies and future commercial manufacturing.
Rob joined Ardena in 2018 as a Process Development Scientist in the field of Nanomedicines. Since then, he has focused on supporting process development and manufacturing scale-up activities for advanced therapeutic programs within GMP-regulated environments. Prior to joining Ardena, he completed a two-year postdoctoral position in Paris specializing in polymer and materials sciences.
Rob obtained his PhD in Supramolecular Chemistry from Eindhoven University of Technology in 2015.
